Andres Liivak
Andres Liivak focuses his practice on structuring and negotiating complex business arrangements for life sciences and technology companies worldwide. He works extensively with emerging and advanced technologies, including biotechnology, pharmaceuticals, medical devices and emerging data and algorithm-driven technologies. Andres takes a leading role in advising clients on major deals involving collaboration licensing arrangements, M&A, carve-out and joint venture deals, and commercial contract and IP disputes and settlements. He frequently represents leading multinational pharmaceutical and technology firms, Europe- and Japan-headquartered corporations, emerging biotechnology companies, and global medical device businesses.
Drawing on extensive industry knowledge gained over more than 25 years, Andres provides pragmatic business driven advice to clients across the full life cycle of their businesses and products—from discovery and development to manufacturing through commercialization, involving business, intellectual property, regulatory and legal compliance, market entry, and competition concerns. His broad perspective helps clients through complex transactions and business challenges at every stage. Andres’s experience ranges across the full spectrum of technology, including small molecule, biologicals, cell and gene therapies, and vaccines for both branded and generic drugs and medical devices as well as data- and algorithm-based technology business arrangements including quantum computing technologies and imaging and image processing for human health and animal health applications and healthtech businesses.
